Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Veteran's asthma evaluation is being remanded for additional development and clarification due to conflicting medical records regarding the frequency of her asthma exacerbations and use of corticosteroids or immunosuppressive medications.

The deciding factor: Conflicting medical evidence regarding the frequency of asthma exacerbations and use of corticosteroids or immunosuppressive medications prevents a clear determination on the Veteran's claim.

Claimed conditions
Asthma
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
None in this decision
Decision date
September 18, 2017
Citation
1740314

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1740314.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.